To analyse the ability of PFKFB4 to reverse drug resistance, we established three BC xenograft models by subcutaneously implanting normal MCF‐7 cells and genetically modifying MCF‐7 cells, overexpressing or knocking down PFKFB4, into immunodeficient mice. This evidence concerns the gene PFKFB4 and breast cancer.